Cargando…
Clinical recommendations on lung cancer management during the COVID‐19 pandemic
Coronavirus disease 2019 (COVID‐19) is spreading worldwide, and has been declared as an international public health concern. Patients with lung cancer are highly susceptible to infection compared to healthy individuals because of systemic immunosuppression induced by malignancy and anticancer therap...
Autores principales: | Xu, Yan, Liu, Hongsheng, Hu, Ke, Wang, Mengzhao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons Australia, Ltd
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7283707/ https://www.ncbi.nlm.nih.gov/pubmed/32469164 http://dx.doi.org/10.1111/1759-7714.13498 |
Ejemplares similares
-
Recommendation for Resuming Elective Surgery during the Normalising Period in COVID-19 Pandemic
por: Sungur, Zerrin, et al.
Publicado: (2021) -
Recommendations of individualized medical treatment and common adverse events management for lung cancer patients during the outbreak of COVID‐19 epidemic
por: Zhao, Zhe, et al.
Publicado: (2020) -
Heat stroke management during the COVID‐19 pandemic: Recommendations from the experts in Japan (2nd edition)
por: Kanda, Jun, et al.
Publicado: (2023) -
SAGES and EAES recommendations for minimally invasive surgery during COVID-19 pandemic
por: Francis, Nader, et al.
Publicado: (2020) -
Recommendations for equitable COVID-19 pandemic recovery in Canada
por: Persaud, Nav, et al.
Publicado: (2021)